Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. - Test2 - elhamkhani - TriplyDB

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

http://www.wikidata.org/entity/Q38450711

about

Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma.Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cells.A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib.A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death.Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.HMQ-T-B10 induces human liver cell apoptosis by competitively targeting EphrinB2 and regulating its pathway

P2860

Q33899239-B69ACDEE-F7E0-4C1B-B83D-C37E86CEC7CF Q35866050-2F2E8FFE-22C9-4E97-8F93-12130D23DFC1 Q37269227-03C65313-931E-4EE6-BCB2-EF3916157560 Q37496567-A6ECAAAF-196A-4EDA-A225-AFF9093EA2F3 Q37571904-799CCB37-61D1-45FB-8C32-79642CDBBE18 Q37701253-C91927D5-192D-4DE9-A6B1-B4FB1CD17794 Q38632417-56EDD2C1-457B-4570-9BD0-67E1FF1DA932 Q38777365-8472EAB8-E327-402B-BB35-919A3CD27B48 Q38821041-40ACB208-BB86-446E-A141-D96DA85FEBA4 Q42368651-5DCB0CFB-90AA-4452-87D5-F30E6F6DF805 Q58738086-2290A5BC-42FC-4BF3-AF49-ED96A188DF75

P2860

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

http://www.wikidata.org/entity/Q38450711

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

@en

type

label

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

@en

prefLabel

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

@en

P1433

Q38450711-6972C968-EB41-4A84-87A6-832ED9EE42A3

P1476

Q38450711-69BE6847-0EEC-4435-85D0-DBAB41219C0A

P2093

Q38450711-6CDD30E3-2BA9-4B8C-9976-980A440EA314

Q38450711-DC750698-2DC6-4CD4-B4B0-D6129F1133AF

Q38450711-E94F8226-03DD-47F9-9A27-4B02A4C8953E

P2860

Q38450711-047FC4FC-EC21-4946-AD50-5AF991642C84

Q38450711-06AF752F-4265-4E2C-98EF-2FC99CB8D26D

Q38450711-09E2396A-3F76-4E97-9703-D07FE0EFD658

Q38450711-0EA548B8-0510-4ED8-8AFC-927D66BF313E

Q38450711-0ECCF6D3-2340-497C-834E-37A44E09E7E2

Q38450711-106BF6C8-B095-4728-ACA5-16B5A9F88B74

Q38450711-16E64E49-845C-4029-AF17-F37DAD569B2A

Q38450711-22FA1879-7DED-47DC-8D1B-9D2BB8BC6B5C

Q38450711-231FF514-C697-4499-90DA-BD0CD29A7D6F

Q38450711-232A2629-3A14-4AD0-A80B-00D25ADCA242

P304

Q38450711-BA4BE1A0-8220-4E14-90EF-15A4BE5E114A

P31

Q38450711-BCFB7BA8-F0F9-433B-B396-EEEA08680790

P356

Q38450711-29684614-395D-4834-B30A-9B727EBDF500

P478

Q38450711-486EF7C8-47D8-409F-9666-EF393A88CC98

P50

Q38450711-C48C971F-D5C4-4184-A14A-08C8DC84382F

Q38450711-DBBC799F-47E7-4B05-9F46-E79361BE45AF

P577

Q38450711-9AE01EC8-E674-447C-A2CC-27456650E677

P5875

Q38450711-5020037B-8CA4-4080-B5F0-E803DD979292

P698

Q38450711-640AA14D-6B47-473F-86D5-F61A484C4672

P921

Q38450711-289B1024-7A58-4A2A-A6DC-BAB9B933BF8B

P932

Q38450711-BCB76CA3-B951-4C07-84F5-3B224AB3422A

P356

P1433

Hepatic Medicine: Evidence and Research

P1476

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility

@en

P2093

José Luis Montero-Álvarez

http://www.w3.org/2001/XMLSchema#string

Manuel de la Mata

http://www.w3.org/2001/XMLSchema#string

Patricia Aguilar-Melero

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers for hepatocellular carcinoma

Oncogenes and Cancer

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma

Epigenetics in liver disease

The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update

Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma

Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

The fundamental role of epigenetic events in cancer

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/HMER.S50161

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Gustavo Ferrín

Manuel Rodríguez-Perálvarez

P577

2015-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275251615

http://www.w3.org/2001/XMLSchema#string

P698

25926760

http://www.w3.org/2001/XMLSchema#string

P921

P932

4403743

http://www.w3.org/2001/XMLSchema#string